Insights into neurological dysfunction of critically ill COVID-19 patients
- PMID: 38620281
- PMCID: PMC7490585
- DOI: 10.1016/j.tacc.2020.09.005
Insights into neurological dysfunction of critically ill COVID-19 patients
Abstract
Novel coronavirus spread rapidly around the world infecting millions of people. It was thus declared a pandemic. This new virus damages the lungs. In the most severe cases, it leads to acute respiratory failure that requires intensive care treatment. However, many clinical reports have listed different neurological symptoms, leading to increased interest in the neurological involvement of COVID-19. Various pathophysiological mechanisms have been proposed to explain these neurological aspects. Direct viral invasion of the nervous system, systemic cytokine storm and severe hypoxemia are key factors in the development of symptoms. Critically ill patients present several additional risk factors for nervous system damage. Reasons for these include deep sedation and extended muscular paralysis, bed rest for several days, and the inability to receive proper physical rehabilitation. After ICU treatment, COVID-19 patients generally require an extensive rehabilitation program. However, distancing restrictions mean that in many cases physiotherapists are unable to enter ICUs, delaying the process of rehabilitation. The role of telemedicine should be considered as an adjunctive tool in the rehabilitation of critically ill COVID-19 patients.
Keywords: Acute neurological involvement; Acute respiratory failure; COVID-19; Critically ill patients; Neurology; Rehabilitation.
© 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
All authors declare no conflict of interest. Prof. Luigi Vetrugno received travel support for Congress lecture by Cook Medical.
Figures
Similar articles
-
Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.Pain Physician. 2020 Mar;23(2):E71-E83. Pain Physician. 2020. PMID: 32214286
-
Therapeutic respiratory and functional rehabilitation protocol for intensive care unit patients affected by COVID-19: a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 12;22(1):268. doi: 10.1186/s13063-021-05210-y. Trials. 2021. PMID: 33845878 Free PMC article.
-
Myoclonus status revealing COVID 19 infection.Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22. Seizure. 2023. PMID: 36446232 Free PMC article.
-
Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013819. doi: 10.1002/14651858.CD013819. Cochrane Database Syst Rev. 2020. PMID: 33348427 Free PMC article.
-
Evidence-Based Management of the Critically Ill Adult With SARS-CoV-2 Infection.J Intensive Care Med. 2021 Jan;36(1):18-41. doi: 10.1177/0885066620969132. Epub 2020 Oct 28. J Intensive Care Med. 2021. PMID: 33111601 Review.
Cited by
-
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study).Pulmonology. 2023 Nov-Dec;29(6):457-468. doi: 10.1016/j.pulmoe.2022.11.002. Epub 2022 Nov 24. Pulmonology. 2023. PMID: 36669936 Free PMC article.
-
Association between COVID-19 and Postoperative Neurological Complications and Antipsychotic Medication Use after Cancer Surgery: A Retrospective Study.J Pers Med. 2023 Jan 31;13(2):274. doi: 10.3390/jpm13020274. J Pers Med. 2023. PMID: 36836508 Free PMC article.
-
Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series.Brain Hemorrhages. 2022 Mar;3(1):29-35. doi: 10.1016/j.hest.2021.12.002. Epub 2021 Dec 13. Brain Hemorrhages. 2022. PMID: 34927033 Free PMC article.
-
Cerebral Hemodynamics and Intracranial Compliance Impairment in Critically Ill COVID-19 Patients: A Pilot Study.Brain Sci. 2021 Jun 30;11(7):874. doi: 10.3390/brainsci11070874. Brain Sci. 2021. PMID: 34208937 Free PMC article.
-
Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.Rev Bras Ter Intensiva. 2022 Nov 4;34(3):342-350. doi: 10.5935/0103-507X.20220229-pt. eCollection 2022. Rev Bras Ter Intensiva. 2022. PMID: 36351066 Free PMC article. Clinical Trial.
References
-
- World Health Organization website https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
-
- World Health Organization website https://www.who.int/docs/default-source/coronaviruse/situation-reports/2...
-
- Worldmeters data source https://www.worldometers.info/coronavirus/
-
- Asadi-Pooya A.A., Simani L. Central nervous system manifestations of COVID-19: a systematic review. J. Neurol. Sci. 2020;413 htpps://doi:10.1016/j.jns.2020.116832 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources